Cargando…

Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients

PURPOSE: Various parameters have been proposed to predict the outcome of patients with coronavirus disease. The aim of this study was to evaluate the utility of the age-adjusted CCI score and biochemical parameters for predicting outcomes for COVID-19 patients on admission. PATIENTS AND METHODS: A t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavuşoğlu Türker, Betül, Türker, Fatih, Ahbab, Süleyman, Hoca, Emre, Urvasızoğlu, Ayşe Oznur, Cetin, Seher Irem, Ataoğlu, Hayriye Esra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343174/
https://www.ncbi.nlm.nih.gov/pubmed/35924178
http://dx.doi.org/10.2147/IJGM.S374246
_version_ 1784760953065177088
author Cavuşoğlu Türker, Betül
Türker, Fatih
Ahbab, Süleyman
Hoca, Emre
Urvasızoğlu, Ayşe Oznur
Cetin, Seher Irem
Ataoğlu, Hayriye Esra
author_facet Cavuşoğlu Türker, Betül
Türker, Fatih
Ahbab, Süleyman
Hoca, Emre
Urvasızoğlu, Ayşe Oznur
Cetin, Seher Irem
Ataoğlu, Hayriye Esra
author_sort Cavuşoğlu Türker, Betül
collection PubMed
description PURPOSE: Various parameters have been proposed to predict the outcome of patients with coronavirus disease. The aim of this study was to evaluate the utility of the age-adjusted CCI score and biochemical parameters for predicting outcomes for COVID-19 patients on admission. PATIENTS AND METHODS: A total of 511 patients were included in the study. Only swab or serological tests positive patients were included. The clinical characteristics of the patients were compared between survival and non-survival COVID-19 inpatients. Hemoglobin, platelet, sedimentation, creatinine, AST, ALT, LDH, CK, albumin, ferritin, lymphocyte, neutrophil, CRP (1–5;5–10;10–20 × upper limit), procalcitonin (5–10;10–20; > 20 × upper limit), D Dimer (> 2 × upper limit), age, gender, chronic diseases and CCI scores were compared between the two groups. RESULTS: 68 patients died and 443 patients survived. Mean age was 74.3±7.3 years in survival group and 76.7±8.0 in nonsurvival group. Age, male sex, ischemic heart disease (CHD), chronic kidney disease and active malignancy was statistically higher in non-survivor group. The biochemical parameters was compared in survival and nonsurvival group. CCI score, AST, LDH, CK, Ferritin, CRP are significantly higher and albumin, lymphocyte levels are significantly lower in nonsurvival group. D-dimer and procalcitonin levels are significantly higher in nonsurvival group. CCI score and neutrophil, creatinine, ALT, AST, d-dimer and procalcitonin elevations were correlated. Low albumin and lymphocyte levels were correlated with the CCI score. There was no significant correlation between ferritin, sedimentation, CRP levels and CCI score. A multivariate logistic regression analysis indicated that anaemia, elevated CRP (> 10–20 × upper limit), procalcitonin (> 5–10 × upper limit), ALT, AST levels and higher CCI score were independent risk factors for mortality in COVID-19 patients. CONCLUSION: Anaemia, elevated CRP, procalcitonin levels, ALT, AST levels and higher CCI score were found independent risk factors for mortality in COVID-19 patients.
format Online
Article
Text
id pubmed-9343174
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93431742022-08-02 Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients Cavuşoğlu Türker, Betül Türker, Fatih Ahbab, Süleyman Hoca, Emre Urvasızoğlu, Ayşe Oznur Cetin, Seher Irem Ataoğlu, Hayriye Esra Int J Gen Med Original Research PURPOSE: Various parameters have been proposed to predict the outcome of patients with coronavirus disease. The aim of this study was to evaluate the utility of the age-adjusted CCI score and biochemical parameters for predicting outcomes for COVID-19 patients on admission. PATIENTS AND METHODS: A total of 511 patients were included in the study. Only swab or serological tests positive patients were included. The clinical characteristics of the patients were compared between survival and non-survival COVID-19 inpatients. Hemoglobin, platelet, sedimentation, creatinine, AST, ALT, LDH, CK, albumin, ferritin, lymphocyte, neutrophil, CRP (1–5;5–10;10–20 × upper limit), procalcitonin (5–10;10–20; > 20 × upper limit), D Dimer (> 2 × upper limit), age, gender, chronic diseases and CCI scores were compared between the two groups. RESULTS: 68 patients died and 443 patients survived. Mean age was 74.3±7.3 years in survival group and 76.7±8.0 in nonsurvival group. Age, male sex, ischemic heart disease (CHD), chronic kidney disease and active malignancy was statistically higher in non-survivor group. The biochemical parameters was compared in survival and nonsurvival group. CCI score, AST, LDH, CK, Ferritin, CRP are significantly higher and albumin, lymphocyte levels are significantly lower in nonsurvival group. D-dimer and procalcitonin levels are significantly higher in nonsurvival group. CCI score and neutrophil, creatinine, ALT, AST, d-dimer and procalcitonin elevations were correlated. Low albumin and lymphocyte levels were correlated with the CCI score. There was no significant correlation between ferritin, sedimentation, CRP levels and CCI score. A multivariate logistic regression analysis indicated that anaemia, elevated CRP (> 10–20 × upper limit), procalcitonin (> 5–10 × upper limit), ALT, AST levels and higher CCI score were independent risk factors for mortality in COVID-19 patients. CONCLUSION: Anaemia, elevated CRP, procalcitonin levels, ALT, AST levels and higher CCI score were found independent risk factors for mortality in COVID-19 patients. Dove 2022-07-27 /pmc/articles/PMC9343174/ /pubmed/35924178 http://dx.doi.org/10.2147/IJGM.S374246 Text en © 2022 Cavuşoğlu Türker et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Cavuşoğlu Türker, Betül
Türker, Fatih
Ahbab, Süleyman
Hoca, Emre
Urvasızoğlu, Ayşe Oznur
Cetin, Seher Irem
Ataoğlu, Hayriye Esra
Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
title Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
title_full Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
title_fullStr Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
title_full_unstemmed Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
title_short Evaluation of the Charlson Comorbidity Index and Laboratory Parameters as Independent Early Mortality Predictors in Covid 19 Patients
title_sort evaluation of the charlson comorbidity index and laboratory parameters as independent early mortality predictors in covid 19 patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343174/
https://www.ncbi.nlm.nih.gov/pubmed/35924178
http://dx.doi.org/10.2147/IJGM.S374246
work_keys_str_mv AT cavusogluturkerbetul evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients
AT turkerfatih evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients
AT ahbabsuleyman evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients
AT hocaemre evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients
AT urvasızogluayseoznur evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients
AT cetinseherirem evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients
AT ataogluhayriyeesra evaluationofthecharlsoncomorbidityindexandlaboratoryparametersasindependentearlymortalitypredictorsincovid19patients